[Federal Register Volume 87, Number 150 (Friday, August 5, 2022)]
[Notices]
[Pages 48028-48029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16806]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463.
    Name of Committee: Safety and Occupational Health Study Section 
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).

[[Page 48029]]

    Dates: October 4-5, 2022.
    Times: 11:00 a.m.-5:00 p.m., EDT.
    Place: Teleconference.
    Agenda: The meeting will convene to address matters related to the 
conduct of Study Section business and for the Study Section to consider 
safety and occupational health-related grant applications.

FOR FURTHER INFORMATION CONTACT:  Michael Goldcamp, Ph.D., Scientific 
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, West Virginia 
26506; Telephone: (304) 285-5951; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16806 Filed 8-4-22; 8:45 am]
BILLING CODE 4163-18-P